Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

Delayed Data
As of Jan 21
 -1.66 / -3.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 88.00, with a high estimate of 106.00 and a low estimate of 45.00. The median estimate represents a +73.06% increase from the last price of 50.85.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 26.74%
Growthannually 30.84%


Growthquarterly 24.88%
Growthannually 111.98%
Key to the earnings and sales forecast charts.